KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 80 filers reported holding KINNATE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,321 | -91.4% | 24,515 | -81.4% | 0.00% | – |
| Q2 2023 | $398,424 | +288.4% | 131,493 | +701.2% | 0.00% | – |
| Q1 2023 | $102,569 | +33.8% | 16,411 | +30.6% | 0.00% | – |
| Q4 2022 | $76,671 | -47.8% | 12,569 | +8.0% | 0.00% | – |
| Q2 2022 | $147,000 | -39.0% | 11,636 | +92.4% | 0.00% | – |
| Q4 2020 | $241,000 | – | 6,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |